Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kay W.P. Ng
Low-Dose Versus Standard-Dose Tissue Plasminogen Activator for Intravenous Thrombolysis in Asian Acute Ischemic Stroke Patients
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Related publications
Response to Letter Regarding Article, “Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Stroke Is Better Than Low Doses”
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Low-Dose Tissue Plasminogen Activator for Calciphylaxis
Archives of Dermatology
Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Ischemic Stroke Patients Over 80 Years Old: The Fukuoka Stroke Registry
PLoS ONE
Multidisciplinary
Predictors of Systemic Inflammatory Response Syndrome in Ischemic Stroke Undergoing Systemic Thrombolysis With Intravenous Tissue Plasminogen Activator
Journal of Stroke and Cerebrovascular Diseases
Surgery
Neurology
Cardiovascular Medicine
Rehabilitation
Cardiology
Systemic Review : Role of Tissue Plasminogen Activator for Acute Ischemic Stroke
The Egyptian Journal of Hospital Medicine
Tissue Plasminogen Activator-Based Nanothrombolysis for Ischemic Stroke
Expert Opinion on Drug Delivery
Pharmaceutical Science
Practical Model-Based Dose Finding in Early-Phase Clinical Trials: Optimizing Tissue Plasminogen Activator Dose for Treatment of Ischemic Stroke in Children
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Dose Ranging Study of Tissue Plasminogen Activator in Acute Myocardial Infarction.
BMJ
High-Dose Intravenous Naloxone for the Treatment of Acute Ischemic Stroke
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing